Holger Blum

Board of Directors

Holger Blum

Since July 2019 Holger Blum is a Board Member of NovImmune. Holger Blum is founding partner of Patinex Management AG, which provides consulting and advisory services for family offices, corporates and banks. More than 20 years ago he started his career as sell-side healthcare analyst at Deutsche Bank and got voted no 1 in European Biotech and Medtech Research in the Institutional Investor Survey in several years.

In 2014 he became partner of BZ Bank and was in charge of private and public healthcare investments. As such he represented the interests of NovImmune`s majority shareholder and was instrumental in the split and divestment of certain NovImmune assets to Sobi.

Holger Blum graduated with an MBA degree from the University of Mannheim, Germany and Western Illinois University in Macomb, USA.

Back

First patient dosed with NILK-2301 in Phase I clinical trial

First-in-human trial of a CEACAM5xCD3 bispecific κλ body for solid cancer


Read more

LinkedIn